MElll2_Y_Me_Fe_Mn_Cluster Assembly and Maintenance in Ribonucleotide Reductase
核糖核苷酸还原酶中的MEll12_Y_Me_Fe_Mn_簇组装和维护
基本信息
- 批准号:8434673
- 负责人:
- 金额:$ 53.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-02 至 2016-12-31
- 项目状态:已结题
- 来源:
- 关键词:AnabolismAnti-Bacterial AgentsAntibodiesArchitectureBindingBiological AssayCellsComplexCysteineDNA RepairDNA biosynthesisDiphosphatesElectron Nuclear Double ResonanceElectron TransportEnsureEscherichia coliFerredoxinFlavodoxinFree RadicalsFreezingGene DeletionGrowthHemeHousingHumanHydrogenIn VitroIronLigationMaintenanceMediatingMetalsMethodsMolecular ChaperonesNucleosidesNucleotidesOrganismOxidantsPathway interactionsPeptidesPhylogenetic AnalysisPlayProteinsReactionReducing AgentsRibonucleotide ReductaseRoleSaccharomyces cerevisiaeSpectrum AnalysisTherapeuticTherapeutic InterventionTherapeutic UsesX-Ray CrystallographyYeastsantitumor agentcofactorelectron donorhydroxyureain vivointerestmicroorganismpathogenpublic health relevancerepairedself assemblysmall moleculetherapeutic targettime usetool
项目摘要
DESCRIPTION (provided by applicant): Ribonucleotide reductases catalyze the conversion of nucleotides to deoxynucleotides in all organisms supplying the monomeric precursors required for DNA replication and repair. The class Ia and Ib RNRs are composed of two subunits (? and ?) which form the active (?2)n?2 complex. ?2 houses the essential dinuclear-tyrosyl radical (Y) cofactor which in the class Ia RNRs from E. coli, S. cerevisiae, and humans is a diferric cluster (FeIII2-Y), and in the class Ib RNRs from E. coli, B. subtilis, S. sanguinis and many pathogenic microorganisms is likely, a dimanganese cluster (MnIII2- Y). We are interested in how these cofactors are biosynthesized and repaired, i.e., if the Y is reduced inside the cell by endogenous reductants or the chemotherapeutic hydroxyurea, how the MeIII2-cluster is re-converted to active cofactor. Studies of self-assembly of FeIII2-Y in the Ia RNRs in vitro have demonstrated the requirement for reducing equivalents, and controlled metal and oxidant delivery. We have recently discovered in E. coli, a 2Fe2S cluster ferredoxin (YfaE) that plays a role in electron transfer in cluster biosynthesis and maintenance and likely is involved in cluster
metallation. In assembly of the eukaryotic class Ia cluster in S. cerevisiae, Dre2 and Tah18 are proposed to play a similar role in electron transfer for biosynthesis and maintenance and Grx3/Grx4 and Dre2/Tah18 are proposed to play a role in metallation. While the class Ib RNRs can also self-assemble FeIII2-Y active in nucleotide reduction, our recent studies suggest that the active cofactor in vivo is MnIII2-Y cluster and that its assembly in vitro and in vivo require an unusual flavodoxin, NrdI. The present proposal is focused on obtaining evidence for the roles of the protein factors in vivo (E. coli and S. cerevisiae) using the tools we have developed over the last few years (whole cell EPR, antibodies, activity assays, isogenic strains with gene deletions and conditional expression and X-ray crystallography). We are also investigating the mechanism of MnIII2-Y cofactor assembly using time resolved biophysical methods (stopped flow, rapid freeze quench EPR and EXAFS spectroscopies). The observation of the long ago postulated, but elusive, Mn-RNR raises the importance of the competition between pathogens and their hosts for controlled metallation and suggests new targets for antibacterial therapeutics.
描述(由申请人提供):核糖核苷酸还原酶催化所有生物体中核苷酸向脱氧核苷酸的转化,提供DNA复制和修复所需的单体前体。 Ia 类和 Ib 类 RNR 由两个亚基 (? 和 ?) 组成,形成活性 (?2)n?2 复合物。 ?2 包含必需的双核酪氨酰自由基 (Y ) 辅助因子,其在来自大肠杆菌、酿酒酵母和人类的 Ia 类 RNR 中是一个二铁簇 (FeIII2-Y ),而在来自大肠杆菌的 Ib 类 RNR 中是一个二铁簇 (FeIII2-Y )大肠杆菌、枯草芽孢杆菌、血链球菌和许多病原微生物可能是二锰簇 (MnIII2-Y)。我们感兴趣的是这些辅因子是如何生物合成和修复的,即,如果细胞内的 Y 被内源性还原剂或化疗羟基脲还原,MeIII2 簇如何重新转化为活性辅因子。 Ia RNR 中 FeIII2-Y 体外自组装的研究表明需要还原当量以及受控金属和氧化剂输送。我们最近在大肠杆菌中发现了一种 2Fe2S 簇铁氧还蛋白 (YfaE),它在簇生物合成和维持中的电子转移中发挥作用,并且可能参与簇
金属化。在酿酒酵母真核 Ia 类簇的组装中,Dre2 和 Tah18 被认为在生物合成和维持的电子转移中发挥类似的作用,Grx3/Grx4 和 Dre2/Tah18 被认为在金属化中发挥作用。虽然 Ib 类 RNR 也可以自组装具有核苷酸还原活性的 FeIII2-Y,但我们最近的研究表明,体内的活性辅因子是 MnIII2-Y 簇,并且其体外和体内组装需要一种不寻常的黄素氧还蛋白 NrdI 。本提案的重点是使用我们在过去几年开发的工具(全细胞 EPR、抗体、活性测定、同基因菌株与基因缺失和条件表达以及 X 射线晶体学)。我们还在利用时间分辨生物物理方法(停流、快速冷冻淬灭 EPR 和 EXAFS 光谱)研究 MnIII2-Y 辅因子组装的机制。对很久以前假设但难以捉摸的 Mn-RNR 的观察提高了病原体与其宿主之间对受控金属化的竞争的重要性,并为抗菌治疗提出了新的靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOANNE STUBBE其他文献
JOANNE STUBBE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOANNE STUBBE', 18)}}的其他基金
LONG RANGE RADICAL INITIATION IN E COLI RIBONUCLEOTIDE REDUCTASE
大肠杆菌核糖核苷酸还原酶中的长程自由基引发
- 批准号:
8172106 - 财政年份:2010
- 资助金额:
$ 53.44万 - 项目类别:
LONG RANGE RADICAL INITIATION IN E COLI RIBONUCLEOTIDE REDUCTASE
大肠杆菌核糖核苷酸还原酶中的长程自由基引发
- 批准号:
7956623 - 财政年份:2009
- 资助金额:
$ 53.44万 - 项目类别:
Ribonucleotide Reductase Regulation: Diferric Y* assembly/maintenance and Sml1
核糖核苷酸还原酶调节:Diferric Y* 组装/维护和 Sml1
- 批准号:
7941310 - 财政年份:2009
- 资助金额:
$ 53.44万 - 项目类别:
LONG RANGE RADICAL INITIATION IN E COLI RIBONUCLEOTIDE REDUCTASE
大肠杆菌核糖核苷酸还原酶中的长程自由基引发
- 批准号:
7723929 - 财政年份:2008
- 资助金额:
$ 53.44万 - 项目类别:
Ribonucleotide Reductase Regulation: Diferric Y* assembly/maintenance and Sml1
核糖核苷酸还原酶调节:Diferric Y* 组装/维护和 Sml1
- 批准号:
7648196 - 财政年份:2008
- 资助金额:
$ 53.44万 - 项目类别:
Ribonucleotide Reductase Regulation: Diferric Y* assembly/maintenance and Sml1
核糖核苷酸还原酶调节:Diferric Y* 组装/维护和 Sml1
- 批准号:
8448436 - 财政年份:2008
- 资助金额:
$ 53.44万 - 项目类别:
MElll2_Y_Me_Fe_Mn_Cluster Assembly and Maintenance in Ribonucleotide Reductase
核糖核苷酸还原酶中的MEll12_Y_Me_Fe_Mn_簇组装和维护
- 批准号:
8605195 - 财政年份:2008
- 资助金额:
$ 53.44万 - 项目类别:
Ribonucleotide Reductase Regulation: Diferric Y* assembly/maintenance and Sml1
核糖核苷酸还原酶调节:Diferric Y* 组装/维护和 Sml1
- 批准号:
7527517 - 财政年份:2008
- 资助金额:
$ 53.44万 - 项目类别:
Ribonucleotide Reductase Regulation: Diferric Y* assembly/maintenance and Sml1
核糖核苷酸还原酶调节:Diferric Y* 组装/维护和 Sml1
- 批准号:
7802291 - 财政年份:2008
- 资助金额:
$ 53.44万 - 项目类别:
Ribonucleotide Reductase Regulation: Diferric Y* assembly/maintenance and Sml1
核糖核苷酸还原酶调节:Diferric Y* 组装/维护和 Sml1
- 批准号:
8069355 - 财政年份:2008
- 资助金额:
$ 53.44万 - 项目类别:
相似国自然基金
基于呫吨酮的拟肽抗菌剂设计合成、抗菌活性和分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
脑靶向新型反义抗菌剂递送系统的构建、评价及其递送机理研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
土壤真菌群落对典型三唑类抗菌剂的抗药性响应特征和机制
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
二(苯乙烯基)酮类光敏抗菌剂的设计,合成及应用研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
基于声动力的高效靶向抗菌剂开发及其用于幽门螺杆菌感染治疗的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Harnessing iron acquisition to hinder enterobacterial pathogenesis
利用铁的获取来阻碍肠细菌的发病机制
- 批准号:
10651432 - 财政年份:2023
- 资助金额:
$ 53.44万 - 项目类别:
Uniquely constrained peptides for modulating TNF receptor activity
用于调节 TNF 受体活性的独特限制肽
- 批准号:
10387498 - 财政年份:2022
- 资助金额:
$ 53.44万 - 项目类别:
Pathogen-host interactions in Lyme disease interrogated at Single Cell Level
在单细胞水平上探讨莱姆病的病原体与宿主的相互作用
- 批准号:
10388319 - 财政年份:2021
- 资助金额:
$ 53.44万 - 项目类别:
Novel therapeutic approaches for treatment of drug-resistant Gram-positive infections
治疗耐药革兰氏阳性菌感染的新方法
- 批准号:
10301362 - 财政年份:2020
- 资助金额:
$ 53.44万 - 项目类别:
Design and Development of Immunotolerant S. aureus Biotherapies
免疫耐受金黄色葡萄球菌生物疗法的设计和开发
- 批准号:
9253183 - 财政年份:2015
- 资助金额:
$ 53.44万 - 项目类别: